Takeda Pharmaceutical Co. net profit according to IFRS for 9 months of fiscal year 2020 was ¥179.027 billion, up 4.2 times from ¥42.728 billion in the previous year. Revenue fell 3.7% to ¥2.428 trillion from ¥2.52 trillion a year earlier.